Brief: Genedx Reports First Quarter 2023 Financial Results And Business Highlights
GeneDx Holdings Corp WGS.O :
* GENEDX REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
BUSINESS
HIGHLIGHTS
* GENEDX HOLDINGS CORP - REAFFIRMS PRO FORMA FULL YEAR 2023
GUIDANCE
* GENEDX HOLDINGS - GENERATED $40.7 MILLION IN Q1 2023 PRO
FORMA
REVENUE FROM CONTINUING OPERATIONS, REPRESENTING A 7% INCREASE
YEAR OVER YEAR
* GENEDX HOLDINGS CORP - QTRLY LOSS PER SHARE $3.04
Source text for Eikon: ID:nGNX5l0P5g
Further company coverage: WGS.O
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth